Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: hilm who wrote (3723)	6/25/1998 1:53:00 PM
From: Hunter Vann	Read Replies (1) \| Respond to of 9523

Pardon me if this has already been mentioned... On May 19th, a $10 million class action lawsuit was brought against Oxford Health Plans and any other insurer on behalf of all medically diagnosed impotent men who have been denied coverage for all or part of a prescription for the drug Viagra. Industry observers have estimated that about one-half of insurance plans now cover sildenafil therapy. The Health Care Financing Administration may rule that state Medicaid agencies must cover the drug. In the meantime, Medicaid programs have split on the issue, with 11 states covering the drug and 12 others---including those in California, Illinois, New York, and Pennsylvania---just saying no.